Yannick Daniel Muller

[bioRxiv Immunology @biorxiv_immuno]

Redirecting TCR specificity in regulatory T cells toward class I HLA antigens mediates tissue-specific homing https://t.co/9M0vdn9N3d #biorxiv_immuno

[Yannick Daniel Muller @YannickDaMuller]

What a first journey with the lab! So proud of Raphaël Porret for his dedication and commitment to this project and deeply grateful to Ludvig Sollid for sharing his transgenic mice. A huge thanks to everyone for their invaluable help. The show must go on!
https://t.co/CSlSV2uNfc

[Yannick Daniel Muller @YannickDaMuller]

@JAMANetworkOpen Please read the follow-up work completed for this study
https://t.co/wTlnbKKMmi

[Oncology UNIL CHUV @OncoUNILCHUV]

💡NEW STUDY in @jclinicalinvest from @melitairving Lab, Evangelos Stefanidis et al., blends anti-PDL1 + anti-EGFR antibodies with T cells tweaked to pack a punch against tumor cells and unleash macrophages' attack mode.
@Ludwig_Cancer @CHUVLausanne @unil
https://t.co/oaeiOza9I3

[Oncology UNIL CHUV @OncoUNILCHUV]

🎯NEW REVIEW by @IrvingMelita lab from @Ludwig_Cancer, delves into prevalent reasons behind the shortcomings of adoptive T cell therapies (ACT), alongside innovative techniques in T cell engineering aimed at tackling these issues.
@unil @Ludwig_Cancer
➡️https://t.co/E4P2BWP9HA

[Oncology UNIL CHUV @OncoUNILCHUV]

➡️https://t.co/pc3oKusIhH

[Yannick Daniel Muller @YannickDaMuller]

Congrats to Ben and Mathilde for leading this project https://t.co/1L7S9ofH6b

[Human Immunology News @humanimmunenews]

🌟 In a new @natBME study, Dr. @IrvingMelita and colleagues at @Ludwig_Cancer detail the design, production, and applicability of a #lentiviral vector that allowed for the delivery of a variety of genes to human #Tcells. 🧬

#OpenAccess:
🗝️ https://t.co/A77jmD6rW9

[Yannick Daniel Muller @YannickDaMuller]

Matching for HLA-DR excluding diabetogenic HLA-DR3 and HLA-DR4 predicts insulin independence after pancreatic islet transplantation. I had this idea back in 2013. It turns out to be a potentially highly relevant finding to the field! https://t.co/1xZ6uRX8Rw

[JAMA Network Open @JAMANetworkOpen]

The Moderna #COVID19 booster may be associated with new onset chronic urticaria in Switzerland, with limitations in epidemiologic data and confounding by Omicron infection. More research and guidelines are needed. https://t.co/TgAWah8rNv

[FOCIS @FOCISimmunology]

Abstract deadline extended! Due to the number of abstracts currently in progress, FOCIS has made the decision to extend the deadline to submit an abstract. Submit your abstract by 11:59 PM EST Wednesday, January 25, 2023!

Submit an abstract today: https://t.co/dlNahFQYXf

[FOCIS @FOCISimmunology]

Two Weeks Left to Submit an Abstract! Submitting an abstract will allow you to be a part of this not-to-be-missed meeting.

All abstracts must be submitted electronically through the submission site by Wednesday, January 18, 2023 - https://t.co/2PSu8krk2F

[Nick Skartsis @mr1ctla4ig]

Great teamwork and such a privilege to work alongside wonderful colleagues with everyone focused on understanding different aspects of T cell biology.

[Nick Skartsis @mr1ctla4ig]

Novel #biologics that target T effectors, but spare #Tregs are needed for the treatment of #autoimmune diseases and the prevention of #transplant rejection. 50-day free access to our manuscript.
https://t.co/0dzuoLmm9Q

[Faculté de biologie et de médecine (inactif) @FBM_UNIL]

#JobAlert 📣Applications still open for a 𝗗𝗲𝗽𝘂𝘁𝘆 𝗣𝗵𝘆𝘀𝗶𝗰𝗶𝗮𝗻 & 𝗔𝘀𝘀𝗼𝗰𝗶𝗮𝘁𝗲 𝗣𝗿𝗼𝗳𝗲𝘀𝘀𝗼𝗿 at the Lausanne Centre for #Toxicology in Cancer #Immunotherapy
❗️Apply before January 9th, 2023
More info👉https://t.co/ZVxsNH5TCh

@FBM_UNIL @CHUVLausanne @unil

[Department of Immunobiology at UNIL @DIB_UNIL]

The department of Immunobiology @FBM_UNIL is opening a TENURE-TRACK assistant professor position in all fields of immunology! Don't miss this unique opportunity to join a highly interactive and multidisciplinary research center!

[Yannick Daniel Muller @YannickDaMuller]

Check out this interesting observation! Atopic patients, i.e. predisposed to developing specific IgE against common allergens, have better survival than aged-matched non-atopic patients after kidney transplantation! https://t.co/WCo4x1vLgu

[FOCIS @FOCISimmunology]

#FOCIS is pleased to welcome its newest Center of Excellence, The Center of Human Immunology at Lausanne University Hospital (CHIL) in collaboration with the Faculty of Biology and Medicine at the University of Lausanne, Switzerland (CHUV-UNIL)!

[Yannick Daniel Muller @YannickDaMuller]

@FOCISimmunology Such an honor for me to become director of the first FCE in Switzerland! With Laurent Perez, we are representing the newly inaugurated center of human immunology at Lausanne (CHUV-UNIL) #FOCIS, @CHUVLausanne, @unil, @LaurentFBM

[Nature Medicine @NatureMedicine]

#CARTtherapy induced remission in 5 patients with systemic lupus erythematosus.
In our latest News and Views, Jane Salmon @WeillCornell puts the data in context and discusses next steps for the field.
#SLE #lupus #CARTcells
https://t.co/Sga3Up2ujT